Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Breast Cancer
|
November 12, 2020
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer
Sminu Bose, Kevin Kalinsky
Advances in Experimental Medicine and Biology
|
June 28, 2018
Glucose Metabolism in Cancer
Sminu Bose, Anne Le
Advances in Experimental Medicine and Biology
|
May 20, 2021
Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Sminu Bose, Cissy Zhang, Anne Le
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 17, 2022
Novel Therapeutics in the Treatment of Uterine Sarcoma
Sminu Bose, Gary K Schwartz, Matthew Ingham
Frontiers in Oncology
|
March 27, 2023
Therapeutic advances in leiomyosarcoma
Kristine Lacuna, Sminu Bose, Matthew Ingham, et al.
JCO Precision Oncology
|
July 12, 2022
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone
Sminu Bose, Tristan Lee, Shaelyn Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade
Karan Luthria, Parin Shah, Blake Caldwell, et al.
Cell Metabolism
|
January 10, 2012
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells
Anne Le, Andrew N Lane, Max Hamaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Breast Cancer
|
November 12, 2020
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer
Sminu Bose, Kevin Kalinsky
Advances in Experimental Medicine and Biology
|
June 28, 2018
Glucose Metabolism in Cancer
Sminu Bose, Anne Le
Advances in Experimental Medicine and Biology
|
May 20, 2021
Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Sminu Bose, Cissy Zhang, Anne Le
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 17, 2022
Novel Therapeutics in the Treatment of Uterine Sarcoma
Sminu Bose, Gary K Schwartz, Matthew Ingham
Frontiers in Oncology
|
March 27, 2023
Therapeutic advances in leiomyosarcoma
Kristine Lacuna, Sminu Bose, Matthew Ingham, et al.
JCO Precision Oncology
|
July 12, 2022
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone
Sminu Bose, Tristan Lee, Shaelyn Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade
Karan Luthria, Parin Shah, Blake Caldwell, et al.
Cell Metabolism
|
January 10, 2012
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells
Anne Le, Andrew N Lane, Max Hamaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Page
of 1